Instil Bio
Update in progressTIL (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Instil Bio, Inc. is a biopharmaceutical company focused on identifying, evaluating, and advancing therapeutic opportunities. The company seeks to in-license or acquire and develop novel therapeutic candidates targeting diseases with significant unmet medical need. Founded in 2018, Instil Bio is headquartered in Dallas, Texas.
Company score
- Sentiment
- -0.08
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.05
- Governance
- 0.18
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.03
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Bronson Crouch
- Founded2018
- Employees17
- Websiteinstilbio.com
Identifiers
- ISINUS45783C2008
- FIGIBBG00ZGYN521
- CUSIP45783C101
- CIK0001789769